[1] |
Piattelli M, Favero GA, Scarano A, et al. Bone reactions to anorganic bovine bone (Bio-Oss) used in sinus augmentation procedures: A histologic long-term report of 20 cases in humans[J]. Int J Oral Maxillofac Implants, 1999, 14(6): 835-840.
|
[2] |
王敏, 黄志祥, 谭锦辉, 等. 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白局部注射治疗胶原诱导性关节炎大鼠的疗效观察[J]. 中华医学杂志, 2013, 93(37):2989-2992.
|
[3] |
Damerau A, Gaber T, Ohrndorf S, et al. JAK/STAT activation: A general mechanism for bone development, homeostasis, and regeneration[J]. Int J Mol Sci, 2020, 21(23): 9004.
doi: 10.3390/ijms21239004
URL
|
[4] |
Schortinghuis J, Ruben JL, Meijer HJ, et al. Microradiography to evaluate bone growth into a rat mandibular defect[J]. Arch Oral Biol, 2003, 48(2): 155-160.
pmid: 12642235
|
[5] |
Könönen E, Gursoy M, Gursoy UK. Periodontitis: A multifaceted disease of tooth-supporting tissues[J]. J Clin Med, 2019, 8(8): 1135.
doi: 10.3390/jcm8081135
URL
|
[6] |
Jang DI, Lee AH, Shin HY, et al. The role of tumor necrosis factor alpha(TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics[J]. Int J Mol Sci, 2021, 22(5): 2719.
doi: 10.3390/ijms22052719
URL
|
[7] |
Hao Y, Zhu YJ, Zou S, et al. Metabolic syndrome and psoriasis: Mechanisms and future directions[J]. Front Immunol, 2021, 12: 711060.
doi: 10.3389/fimmu.2021.711060
URL
|
[8] |
Menegatti S, Bianchi E, Rogge L. Anti-TNF therapy in spondyloarthritis and related diseases, impact on the immune system and prediction of treatment responses[J]. Front Immunol, 2019, 10: 382.
doi: 10.3389/fimmu.2019.00382
pmid: 30941119
|
[9] |
Zhang Y, Yang CZ, Ge SH, et al. EphB4/TNFR2/ERK/MAPK signaling pathway comprises a signaling axis to mediate the positive effect of TNF-α on osteogenic differentiation[J]. BMC Mol Cell Biol, 2020, 21(1): 29.
doi: 10.1186/s12860-020-00273-2
pmid: 32299362
|
[10] |
Wang JP. Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial[J]. J Int Med Res, 2018, 46(1): 326-334.
doi: 10.1177/0300060517723182
pmid: 28840750
|
[11] |
Sakunrangsit N, Metheepakornchai P, Kumpunya S, et al. Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model[J]. PLoS One, 2021, 16(4): e0250215.
doi: 10.1371/journal.pone.0250215
URL
|
[12] |
Caporali R, Crepaldi G, Codullo V, et al. 20 years of experience with tumour necrosis factor inhibitors: What have we learned?[J]. Rheumatology (Oxford), 2018, 57(7): vii5-vii10.
doi: 10.1093/rheumatology/key059
URL
|
[13] |
Katsumata K, Ishihara J, Fukunaga K, et al. Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-α antibody in a murine model of rheumatoid arthritis[J]. Arthritis Res Ther, 2019, 21(1): 298.
doi: 10.1186/s13075-019-2075-8
pmid: 31870429
|
[14] |
Liu Y, Liao SJ, Bennett S, et al. STAT3 and its targeting inhibitors in osteosarcoma[J]. Cell Prolif, 2021, 54(2): e12974.
doi: 10.1111/cpr.v54.2
URL
|
[15] |
Sanpaolo ER, Rotondo C, Cici D, et al. JAK/STAT pathway and molecular mechanism in bone remodeling[J]. Mol Biol Rep, 2020, 47(11): 9087-9096.
doi: 10.1007/s11033-020-05910-9
pmid: 33099760
|
[16] |
Sims NA. The JAK1/STAT3/SOCS3 axis in bone development, physiology, and pathology[J]. Exp Mol Med, 2020, 52(8): 1185-1197.
doi: 10.1038/s12276-020-0445-6
pmid: 32788655
|
[17] |
Morris R, Kershaw NJ, Babon JJ. The molecular details of cytokine signaling via the JAK/STAT pathway[J]. Protein Sci, 2018, 27(12): 1984-2009.
doi: 10.1002/pro.3519
pmid: 30267440
|
[18] |
Bechman K, Yates M, Galloway JB. The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors[J]. Pharmacol Res, 2019, 147: 104392.
doi: 10.1016/j.phrs.2019.104392
URL
|
[19] |
Wu Z, Liu J, Hu SY, et al. Serine/threonine kinase 35, a target gene of STAT3, regulates the proliferation and apoptosis of osteosarcoma cells[J]. Cell Physiol Biochem, 2018, 45(2): 808-818.
doi: 10.1159/000487172
pmid: 29414823
|